{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:29:05Z","timestamp":1740130145859,"version":"3.37.3"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["COL112055"],"award-info":[{"award-number":["COL112055"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["K24DA034621"],"award-info":[{"award-number":["K24DA034621"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1093\/jac\/dkw009","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T04:40:43Z","timestamp":1455252043000},"page":"1597-1600","source":"Crossref","is-referenced-by-count":5,"title":["Plasma and intracellular ribavirin concentrations are not significantly altered by abacavir in hepatitis C virus-infected patients"],"prefix":"10.1093","volume":"71","author":[{"given":"Edward J.","family":"Fuchs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer J.","family":"Kiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig W.","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Sulkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Radebaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lane","family":"Bushman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle L.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,2,10]]},"reference":[{"key":"2016051405373524000_71.6.1597.1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis927"},{"key":"2016051405373524000_71.6.1597.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.10.021"},{"key":"2016051405373524000_71.6.1597.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02719.x"},{"key":"2016051405373524000_71.6.1597.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.11.009"},{"key":"2016051405373524000_71.6.1597.5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.02.012"},{"key":"2016051405373524000_71.6.1597.6","unstructured":"Gries JM , Torriani FJ , Rodriguez-Torres M et al . Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with HCV\/HIV co-infection: final results of a randomized clinical study. In: Abstracts of the Eleventh Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 2004. Abstract LB 136. Foundation for Retrovirology and Human Health, Alexandria , VA, USA."},{"key":"2016051405373524000_71.6.1597.7","doi-asserted-by":"crossref","first-page":"21509","DOI":"10.1016\/S0021-9258(18)54668-8","article-title":"Mechanism of the potentiating effect of ribavirin on the activity of 2\u2032,3\u2032-dideoxyinosine against human immunodeficiency virus","volume":"266","author":"Balzarini","year":"1991","journal-title":"J Biol Chem"},{"key":"2016051405373524000_71.6.1597.8","unstructured":"Rebetol (Package Insert) . WhitehouseStation, NJ: Merck & Co., 2003."},{"key":"2016051405373524000_71.6.1597.9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/QAI.0b013e318040b2b6","article-title":"Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?","volume":"45","author":"Bani-Sadr","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2016051405373524000_71.6.1597.10","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm373"},{"key":"2016051405373524000_71.6.1597.11","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn420"},{"key":"2016051405373524000_71.6.1597.12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/135965350801300303","article-title":"Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir","volume":"13","author":"Vispo","year":"2008","journal-title":"Antivir Ther"},{"key":"2016051405373524000_71.6.1597.13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1177\/135965350801300709","article-title":"Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin","volume":"13","author":"Laufer","year":"2008","journal-title":"Antivir Ther"},{"key":"2016051405373524000_71.6.1597.14","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1492"},{"key":"2016051405373524000_71.6.1597.15","unstructured":"Berenguer J , von Wichmann M , Quereda C et al . Effect of accompanying antiretroviral drugs on virologic response to PEG-IFN and ribavirin in HIV\/HCV-co-infected patients. In: Abstracts of the Seventeenth Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 2010 . Abstract 663. Foundation for Retrovirology and Human Health, Alexandria, VA, USA."},{"key":"2016051405373524000_71.6.1597.16","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835763a4"},{"key":"2016051405373524000_71.6.1597.17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jchromb.2014.11.032","article-title":"Measurement of intracellular ribavirin mono-, di- and triphosphate using solid phase extraction and LC-MS\/MS quantification","volume":"978\u2013979","author":"Jimmerson","year":"2015","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2016051405373524000_71.6.1597.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2011.05.039"},{"key":"2016051405373524000_71.6.1597.19","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04618-14"},{"key":"2016051405373524000_71.6.1597.20","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv122"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/6\/1597\/6776676\/dkw009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:15:12Z","timestamp":1654301712000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkw009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,10]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,5,14]]},"published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1093\/jac\/dkw009"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw009","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"type":"print","value":"0305-7453"},{"type":"electronic","value":"1460-2091"}],"subject":[],"published":{"date-parts":[[2016,2,10]]}}}